Table 2.
Indications for study sample echocardiograms
| Study sample indication | Percent | N |
|---|---|---|
| Heart failure/cardiomyopathy | 24.0 | 64 |
| Arrhythmia | 11.6 | 31 |
| Chemotherapy | 10.9 | 29 |
| Valve disease | 10.5 | 28 |
| Preoperative exam | 7.9 | 21 |
| Dyspnea | 6.4 | 17 |
| Coronary artery disease | 6.0 | 16 |
| Stroke | 6.0 | 16 |
| Syncope | 5.2 | 14 |
| Rule out endocarditis | 4.9 | 13 |
| Pulmonary HTN | 4.5 | 12 |
| Hypertension | 3.7 | 10 |
| Pericardial effusion | 3.4 | 9 |
| Murmur | 3.0 | 8 |
| Palpitations | 3.0 | 8 |
| Aortic aneurysm | 2.6 | 7 |
| Congenital heart disease | 2.6 | 7 |
| Lung disease | 1.9 | 5 |
| Edema | 1.5 | 4 |
| Hypotension | 1.5 | 4 |
| Cardiac arrest | 0.4 | 1 |
| Heart transplant | 0.4 | 1 |
|
| ||
| Number of normal studiesa | Percent | N |
|
| ||
| Normal studies | 10.9 | 29 |
a
Defined by echo reports documenting normal four-chamber size and systolic/diastolic function, no chamber hypertrophy or wall motion abnormalities, normal valves with trace or less regurgitation, normal great vessels and estimated right atrial pressure, no pericardial effusion, RVSP < 40, and no other abnormalities, such as atherosclerosis, calcification, pleural effusion, ascites, prostheses, or catheters